Leukemia is a type of cancer that affects the blood and bone marrow.
白血病是一种影响血液和骨髓的癌症类型。
He was diagnosed with acute lymphoblastic
leukemia, a severe childhood cancer.
他被诊断为急性淋巴细胞白血病，这是一种严重的儿童癌症。
Treatment for
leukemia often involves chemotherapy and radiation therapy.
白血病的治疗通常包括化疗和放疗。
The patient's
leukemia went into remission after several months of aggressive treatment.
经过几个月的积极治疗，患者的白血病进入了缓解期。
She bravely fought her way through her battle with
leukemia, inspiring many with her strength.
她勇敢地与白血病抗争，以她的坚韧激励了许多人。
A
leukemia survivor shared her story at the charity event to raise awareness and funds for research.
一位白血病幸存者在慈善活动中分享了她的故事，以提高人们对这种疾病的认识并筹集研究资金。
The
leukemia support group provided emotional and practical assistance to those affected by the disease.
白血病支持小组为患病者提供了情感和实际的帮助。
Early detection is crucial in increasing the chances of survival for patients with
leukemia.
早期发现对于白血病患者提高生存率至关重要。
His innovative
leukemia drug showed promising results in clinical trials, bringing hope to millions.
他的创新白血病药物在临床试验中显示出有希望的结果，给数百万人带来了希望。
She dedicated her life to researching
leukemia, hoping to find a cure one day.
她毕生致力于白血病的研究，期待有一天能找到治愈方法。
Suzhou-based domestic biopharmaceutical company Ascentage Pharma said ahead of International Chronic Myeloid Leukemia Day on Wednesday a new application for a drug-resistant CML treatment has been submitted in China.
在周三的国际慢性髓性白血病日之前，苏州本地的生物制药公司Ascentage Pharma表示，已在中国为一种针对药物抵抗性慢性髓性白血病的新型治疗方法提交了新药申请。
A key drug candidate was developed for the treatment of drug-resistant chronic myeloid leukemia, which affects an estimated 10,000 patients in the country each year, said Yang Dajun, chairman and CEO of Ascentage Pharma.
Ascentage Pharma的董事长兼首席执行官杨大俊表示，一个关键的药物候选产品已被开发用于治疗耐药性慢性骨髓性白血病，该疾病每年估计影响全国约1万名患者。
One of the major exhibits at the fair will be its core drug candidate developed for the treatment of drug-resistant chronic myeloid leukemia (CML), which afflicts an estimated 10,000 patients in the country each year, Yang said.
杨说,展览会上的主要展品之一是该公司为治疗对药物产生抗性的慢性骨髓性白血病而研制的核心候选药物;每年国内大约有1万名患者罹患这种疾病。
In June, BeiGene's drug Brukinsa received conditional approval in China as a treatment for adult patients with chronic lymphocytic leukemia or small lymphocytic lymphoma who have received at least one prior therapy, and as a treatment for adult patients with MCL who have received at least one prior therapy.
今年6月， BeiGene的药物Brukinsa在中国获得有条件批准，用于治疗至少接受过一次治疗的成年慢性淋巴细胞白血病或小淋巴细胞淋巴瘤患者，以及至少接受过一次治疗的成年MCL患者。
The drug is for the treatment of adult patients with mantle cell lymphoma who have received at least one prior therapy, and also for adult patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.
这款药物适用于已经接受过至少一次先前治疗的成年弥漫性大B细胞淋巴瘤患者，以及成年慢性淋巴细胞白血病或小淋巴细胞淋巴瘤患者。
I-Mab is also planning to launch Phase 1/2 trials in China among patients with relapsed or refractory acute myeloid leukemia, or myelodysplastic syndrome.
In addition to its significant anti-tumor activity, the drug demonstrated a favorable safety and tolerability profile," saidxa0Li Jianyong, professor and director of thexa0department of hematologyxa0and director of the Pukou chronic lymphocytic leukemia center at thexa0First Affiliated Hospitalxa0ofxa0Nanjing Medical University.
According to the collaboration framework, three vaccines, including one to treat pneumococcus, and at least seven new medicines, including for treating acute myeloid leukemia and non-small-cell long cancer, which have been approved by the United States Food and Drug Administration and the European Medicines Agency for market launch, will be available in the pilot zone soon.
According to their agreement, they will jointly carry out the phase-3 study to access the safety and efficacy of lisaftoclax (APG-2575), an investigational drug developed by Ascentage Pharma, as first-line treatment in combination with AstraZeneca's Calquence (acalabrutinib) for chronic lymphocytic leukemia or small lymphocytic lymphoma patients who have not received any treatment.
Seven years ago, Liu's wife suffered from leukemia.
未经许可，严禁转发。QQ交流群：688169419